One of the most compelling findings is that AAV-2 appears to have no pathologic effects on healthy cells.

So many cancer therapies are as poisonous to healthy cells as they are to cancer cells. A therapy that is able to distinguish between healthy and cancer cells could be less difficult to endure for those with cancer.

We believe that AAV-2 recognizes that the cancer cells are abnormal and destroys them. This suggests that AAV-2 has great potential to be developed as an anti-cancer agent.

Those are suppression activities. Those are not eradication.